Media Coverage

Charles River Labs, CHDI Foundation Pen Boosted Huntington's Disease Pact

exterior of Charles River headquarters at sunset

FierceBiotech

Charles River Laboratories and the privately funded nonprofit biomedical research organization CHDI Foundation have signed a five-year extension for their Huntington's disease work. This pact goes all the way back to 2005 and is based on drug discovery and development efforts for the genetic neurological disease that causes the progressive dysfunction of nerve cells in the brain. "The extension will allow more flexible activity across the different Charles River platforms and entail greater integration into CHDI's programs."

Read the Full Story